Recent Updates
Recently added Catalysts
ELAN Negative Sentiment Score: 20/100

ELANCO ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Elanco Animal Health Incorporated and Encourages Investors to Contact the Firm

Key Takeaway: A class action lawsuit has been filed against Elanco Animal Health Incorporated in the U.S. District Court for the District of Maryland. The lawsuit alleged that Elanco made materially false and misleading statements about its products, particularly Zenrelia. Investors claim these misstatements misrepresented the safety and approval timelines of Elanco's products, leading to an overestimation of the company's financial prospects. Affected investors have until December 6, 2024, to apply to be appointed as lead plaintiff in the case.

Market Sentiment Analysis

CONCERNS & RISKS

  • Class action lawsuit filed against Elanco for misleading statements.
  • Claims made that Zenrelia was less safe than communicated.
  • Elanco's business and financial prospects reportedly overstated.

Full Press Release Details

NEW YORK, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSE: ELAN) in the United States District Court for the District of Maryland on behalf of all persons and entities who purchased or otherwise acquired Elanco securities between November 7, 2023 and June 26, 2024, both dates inclusive (the “Class Period”). Investors have until December 6, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Click here to participate in the action.
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) Zenrelia was less safe than the Company had led investors to believe; (2) Elanco was unlikely to meet its own previously issued timeline for the U.S. approval and commercial launch of both Zenrelia and Credelio Quattro; (3) accordingly, the Company's business and/or financial prospects were overstated; and (4) as a result, the Company's public statements were materially false and misleading at all relevant times.
If you purchased or otherwise acquired Elanco shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
About Bragar Eagel & Squire, P.C.:
Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact Information:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.

Tags

Elanco Animal Health

Frequently Asked Questions

What is the lawsuit against Elanco about?

The lawsuit alleges that Elanco made misleading statements about its business and products.

Who can participate in the class action lawsuit?

Anyone who purchased Elanco securities between November 7, 2023, and June 26, 2024.

What is the deadline to apply to be a lead plaintiff?

Investors have until December 6, 2024, to apply to be the lead plaintiff.

Who should I contact for more information?

Contact Brandon Walker or Marion Passmore via email or phone for details.

Is there a cost to participate in the lawsuit?

No, there is no cost or obligation to participate in the lawsuit.

Last updated: Nov 26, 2024